Advertisement

Index by author

November 01, 1987; Volume 15,Issue 6

A

  1. Abdel-Monem, M M

    1. The disposition and pharmacokinetics of ketoconazole in the rat.
      R P Remmel, K Amoh and M M Abdel-Monem
      Drug Metabolism and Disposition November 1987, 15 (6) 735-739;

  2. Abou-Donia, M B

    1. Disposition, pharmacokinetics, and metabolism of a dermal dose of [14C]2,5-hexanedione in hens.
      E Suwita, A A Nomeir and M B Abou-Donia
      Drug Metabolism and Disposition November 1987, 15 (6) 779-785;

  3. Adelmann, A M

    1. Metabolite profile in milk of lactating rats after treatment with a carcinogen, N-2-fluorenylacetamide.
      D Malejka-Giganti, W J Magat, A M Adelmann and R W Decker
      Drug Metabolism and Disposition November 1987, 15 (6) 760-766;

  4. Allerheiligen, S R

    1. The pharmacokinetics of pentane, a by-product of lipid peroxidation.
      S R Allerheiligen, T M Ludden and R F Burk
      Drug Metabolism and Disposition November 1987, 15 (6) 794-800;

  5. Amoh, K

    1. The disposition and pharmacokinetics of ketoconazole in the rat.
      R P Remmel, K Amoh and M M Abdel-Monem
      Drug Metabolism and Disposition November 1987, 15 (6) 735-739;

B

  1. Barbhaiya, R

    1. N-oxidation of N-methylpyrrolidine released in vivo from cefepime.
      S T Forgue, P Kari and R Barbhaiya
      Drug Metabolism and Disposition November 1987, 15 (6) 808-815;

  2. Barrett, W E

    1. Isolation and identification of major metabolites of tixocortol pivalate in human urine.
      F Chanoine, C Grenot, N Sellier, W E Barrett, R M Thompson, A F Fentiman, J R Nixon, R Goyer and J L Junien
      Drug Metabolism and Disposition November 1987, 15 (6) 868-876;

  3. Bon, M

    1. 19F nuclear magnetic resonance analysis of the carbamate reaction of alpha-fluoro-beta-alanine (FBAL), the major catabolite of fluoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5'-deoxy-5-fluorouridine.
      R Martino, M C Malet-Martino, C Vialaneix, A Lopez and M Bon
      Drug Metabolism and Disposition November 1987, 15 (6) 897-904;

  4. Bories, G F

    1. [3H]chloramphenicol metabolism in human volunteer: oxamic acid as a new major metabolite.
      D E Corpet and G F Bories
      Drug Metabolism and Disposition November 1987, 15 (6) 925-927;

  5. Breyer-Pfaff, U

    1. Phenolic metabolites of amitriptyline and nortriptyline in rat bile.
      U Breyer-Pfaff, A Prox, H Wachsmuth and P P Yao
      Drug Metabolism and Disposition November 1987, 15 (6) 882-889;
    2. Amitriptyline metabolites in human urine. Identification of phenols, dihydrodiols, glycols, and ketones.
      A Prox and U Breyer-Pfaff
      Drug Metabolism and Disposition November 1987, 15 (6) 890-896;

  6. Bulger, W H

    1. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins.
      M J Juedes, W H Bulger and D Kupfer
      Drug Metabolism and Disposition November 1987, 15 (6) 786-793;

  7. Burk, R F

    1. The pharmacokinetics of pentane, a by-product of lipid peroxidation.
      S R Allerheiligen, T M Ludden and R F Burk
      Drug Metabolism and Disposition November 1987, 15 (6) 794-800;

C

  1. Chanoine, F

    1. Isolation and identification of major metabolites of tixocortol pivalate in human urine.
      F Chanoine, C Grenot, N Sellier, W E Barrett, R M Thompson, A F Fentiman, J R Nixon, R Goyer and J L Junien
      Drug Metabolism and Disposition November 1987, 15 (6) 868-876;

  2. Chow, S A

    1. Metabolism and disposition of cyproheptadine and desmethylcyproheptadine in pregnant and fetal rats.
      S A Chow and L J Fischer
      Drug Metabolism and Disposition November 1987, 15 (6) 740-748;

  3. Ciaccio, P J

    1. Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozyme of dog liver cytochrome P-450.
      P J Ciaccio, D B Duignan and J R Halpert
      Drug Metabolism and Disposition November 1987, 15 (6) 852-856;

  4. Cochran, D

    1. Identification of the etodolac metabolite, 4-ureidoetodolac, in mouse, rat, dog, and man.
      E S Ferdinandi, D Cochran and R Gedamke
      Drug Metabolism and Disposition November 1987, 15 (6) 921-924;

  5. Corley, D G

    1. Isolation and characterization of 4'-hydroxy T-2 toxin, a new metabolite of the trichothecene mycotoxin T-2.
      C A Knupp, D G Corley, M S Tempesta and S P Swanson
      Drug Metabolism and Disposition November 1987, 15 (6) 816-820;

  6. Corpet, D E

    1. [3H]chloramphenicol metabolism in human volunteer: oxamic acid as a new major metabolite.
      D E Corpet and G F Bories
      Drug Metabolism and Disposition November 1987, 15 (6) 925-927;

D

  1. Decker, R W

    1. Metabolite profile in milk of lactating rats after treatment with a carcinogen, N-2-fluorenylacetamide.
      D Malejka-Giganti, W J Magat, A M Adelmann and R W Decker
      Drug Metabolism and Disposition November 1987, 15 (6) 760-766;

  2. Duignan, D B

    1. Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozyme of dog liver cytochrome P-450.
      P J Ciaccio, D B Duignan and J R Halpert
      Drug Metabolism and Disposition November 1987, 15 (6) 852-856;

  3. Dulik, D M

    1. Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen, and benoxaprofen.
      M el Mouelhi, H W Ruelius, C Fenselau and D M Dulik
      Drug Metabolism and Disposition November 1987, 15 (6) 767-772;

E

  1. el Mouelhi, M

    1. Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen, and benoxaprofen.
      M el Mouelhi, H W Ruelius, C Fenselau and D M Dulik
      Drug Metabolism and Disposition November 1987, 15 (6) 767-772;

F

  1. Farquhar, D

    1. Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.
      T B Felder, M A McLean, M L Vestal, K Lu, D Farquhar, S S Legha, R Shah and R A Newman
      Drug Metabolism and Disposition November 1987, 15 (6) 773-778;

  2. Feil, V J

    1. Evidence for diazotization of 14C-sulfamethazine [4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzene[U-14C]sulfonamide] in swine. The effect of nitrite.
      G D Paulson and V J Feil
      Drug Metabolism and Disposition November 1987, 15 (6) 841-845;

  3. Felder, T B

    1. Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.
      T B Felder, M A McLean, M L Vestal, K Lu, D Farquhar, S S Legha, R Shah and R A Newman
      Drug Metabolism and Disposition November 1987, 15 (6) 773-778;

  4. Fenselau, C

    1. Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen, and benoxaprofen.
      M el Mouelhi, H W Ruelius, C Fenselau and D M Dulik
      Drug Metabolism and Disposition November 1987, 15 (6) 767-772;

  5. Fentiman, A F

    1. Isolation and identification of major metabolites of tixocortol pivalate in human urine.
      F Chanoine, C Grenot, N Sellier, W E Barrett, R M Thompson, A F Fentiman, J R Nixon, R Goyer and J L Junien
      Drug Metabolism and Disposition November 1987, 15 (6) 868-876;

  6. Ferdinandi, E S

    1. Identification of the etodolac metabolite, 4-ureidoetodolac, in mouse, rat, dog, and man.
      E S Ferdinandi, D Cochran and R Gedamke
      Drug Metabolism and Disposition November 1987, 15 (6) 921-924;

  7. Fischer, L J

    1. Metabolism and disposition of cyproheptadine and desmethylcyproheptadine in pregnant and fetal rats.
      S A Chow and L J Fischer
      Drug Metabolism and Disposition November 1987, 15 (6) 740-748;

  8. Forgue, S T

    1. N-oxidation of N-methylpyrrolidine released in vivo from cefepime.
      S T Forgue, P Kari and R Barbhaiya
      Drug Metabolism and Disposition November 1987, 15 (6) 808-815;

G

  1. Gedamke, R

    1. Identification of the etodolac metabolite, 4-ureidoetodolac, in mouse, rat, dog, and man.
      E S Ferdinandi, D Cochran and R Gedamke
      Drug Metabolism and Disposition November 1987, 15 (6) 921-924;

  2. Goyer, R

    1. Isolation and identification of major metabolites of tixocortol pivalate in human urine.
      F Chanoine, C Grenot, N Sellier, W E Barrett, R M Thompson, A F Fentiman, J R Nixon, R Goyer and J L Junien
      Drug Metabolism and Disposition November 1987, 15 (6) 868-876;

  3. Grenot, C

    1. Isolation and identification of major metabolites of tixocortol pivalate in human urine.
      F Chanoine, C Grenot, N Sellier, W E Barrett, R M Thompson, A F Fentiman, J R Nixon, R Goyer and J L Junien
      Drug Metabolism and Disposition November 1987, 15 (6) 868-876;

  4. Griffeth, L K

    1. Effects of model traumatic injury on hepatic drug metabolism in the rat. VI. Major detoxification/toxification pathways.
      L K Griffeth, G M Rosen and E J Rauchman
      Drug Metabolism and Disposition November 1987, 15 (6) 749-759;

H

  1. Halpert, J R

    1. Mechanism-based inactivation of the major beta-naphthoflavone-inducible isozyme of rat liver cytochrome P-450 by the chloramphenicol analog N-(2-p-nitrophenethyl)dichloroacetamide.
      N E Miller and J R Halpert
      Drug Metabolism and Disposition November 1987, 15 (6) 846-851;
    2. Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozyme of dog liver cytochrome P-450.
      P J Ciaccio, D B Duignan and J R Halpert
      Drug Metabolism and Disposition November 1987, 15 (6) 852-856;

  2. Harigaya, S

    1. Mechanism of metabolic cleavage of a furan ring.
      T Kobayashi, J Sugihara and S Harigaya
      Drug Metabolism and Disposition November 1987, 15 (6) 877-881;

  3. Harvey, D J

    1. Metabolism of (+)-trans-delta 8-tetrahydrocannabinol in the mouse in vitro and in vivo.
      D J Harvey and H J Marriage
      Drug Metabolism and Disposition November 1987, 15 (6) 914-920;

  4. Hendrickx, J

    1. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
      W Meuldermans, J Hendrickx, W Lauwers, R Hurkmans, E Swysen, J Thijssen, P Timmerman, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1987, 15 (6) 905-913;

  5. Heykants, J

    1. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
      W Meuldermans, J Hendrickx, W Lauwers, R Hurkmans, E Swysen, J Thijssen, P Timmerman, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1987, 15 (6) 905-913;

  6. Horning, E C

    1. Conversion of bromobenzene to 3-bromophenol. A route to 3- and 4-bromophenol through sulfur-series intermediates derived from the 3,4-oxide.
      K Lertratanangkoon, E C Horning and M G Horning
      Drug Metabolism and Disposition November 1987, 15 (6) 857-867;

  7. Horning, M G

    1. Conversion of bromobenzene to 3-bromophenol. A route to 3- and 4-bromophenol through sulfur-series intermediates derived from the 3,4-oxide.
      K Lertratanangkoon, E C Horning and M G Horning
      Drug Metabolism and Disposition November 1987, 15 (6) 857-867;

  8. Hurkmans, R

    1. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
      W Meuldermans, J Hendrickx, W Lauwers, R Hurkmans, E Swysen, J Thijssen, P Timmerman, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1987, 15 (6) 905-913;

J

  1. Juedes, M J

    1. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins.
      M J Juedes, W H Bulger and D Kupfer
      Drug Metabolism and Disposition November 1987, 15 (6) 786-793;

  2. Junien, J L

    1. Isolation and identification of major metabolites of tixocortol pivalate in human urine.
      F Chanoine, C Grenot, N Sellier, W E Barrett, R M Thompson, A F Fentiman, J R Nixon, R Goyer and J L Junien
      Drug Metabolism and Disposition November 1987, 15 (6) 868-876;

K

  1. Kari, P

    1. N-oxidation of N-methylpyrrolidine released in vivo from cefepime.
      S T Forgue, P Kari and R Barbhaiya
      Drug Metabolism and Disposition November 1987, 15 (6) 808-815;

  2. Knupp, C A

    1. Isolation and characterization of 4'-hydroxy T-2 toxin, a new metabolite of the trichothecene mycotoxin T-2.
      C A Knupp, D G Corley, M S Tempesta and S P Swanson
      Drug Metabolism and Disposition November 1987, 15 (6) 816-820;

  3. Kobayashi, T

    1. Mechanism of metabolic cleavage of a furan ring.
      T Kobayashi, J Sugihara and S Harigaya
      Drug Metabolism and Disposition November 1987, 15 (6) 877-881;

  4. Kupfer, D

    1. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins.
      M J Juedes, W H Bulger and D Kupfer
      Drug Metabolism and Disposition November 1987, 15 (6) 786-793;

L

  1. Lau, S S

    1. Co-oxidation of 2-bromohydroquinone by renal prostaglandin synthase. Modulation of prostaglandin synthesis by 2-bromohydroquinone and glutathione.
      S S Lau and T J Monks
      Drug Metabolism and Disposition November 1987, 15 (6) 801-807;

  2. Laudenschlager, W G

    1. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
      J A Thompson, A M Malkinson, M D Wand, S L Mastovich, E W Mead, K M Schullek and W G Laudenschlager
      Drug Metabolism and Disposition November 1987, 15 (6) 833-840;

  3. Lauwers, W

    1. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
      W Meuldermans, J Hendrickx, W Lauwers, R Hurkmans, E Swysen, J Thijssen, P Timmerman, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1987, 15 (6) 905-913;

  4. Legha, S S

    1. Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.
      T B Felder, M A McLean, M L Vestal, K Lu, D Farquhar, S S Legha, R Shah and R A Newman
      Drug Metabolism and Disposition November 1987, 15 (6) 773-778;

  5. Lertratanangkoon, K

    1. Conversion of bromobenzene to 3-bromophenol. A route to 3- and 4-bromophenol through sulfur-series intermediates derived from the 3,4-oxide.
      K Lertratanangkoon, E C Horning and M G Horning
      Drug Metabolism and Disposition November 1987, 15 (6) 857-867;

  6. Lopez, A

    1. 19F nuclear magnetic resonance analysis of the carbamate reaction of alpha-fluoro-beta-alanine (FBAL), the major catabolite of fluoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5'-deoxy-5-fluorouridine.
      R Martino, M C Malet-Martino, C Vialaneix, A Lopez and M Bon
      Drug Metabolism and Disposition November 1987, 15 (6) 897-904;

  7. Lu, K

    1. Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.
      T B Felder, M A McLean, M L Vestal, K Lu, D Farquhar, S S Legha, R Shah and R A Newman
      Drug Metabolism and Disposition November 1987, 15 (6) 773-778;

  8. Ludden, T M

    1. The pharmacokinetics of pentane, a by-product of lipid peroxidation.
      S R Allerheiligen, T M Ludden and R F Burk
      Drug Metabolism and Disposition November 1987, 15 (6) 794-800;

M

  1. Magat, W J

    1. Metabolite profile in milk of lactating rats after treatment with a carcinogen, N-2-fluorenylacetamide.
      D Malejka-Giganti, W J Magat, A M Adelmann and R W Decker
      Drug Metabolism and Disposition November 1987, 15 (6) 760-766;

  2. Malejka-Giganti, D

    1. Metabolite profile in milk of lactating rats after treatment with a carcinogen, N-2-fluorenylacetamide.
      D Malejka-Giganti, W J Magat, A M Adelmann and R W Decker
      Drug Metabolism and Disposition November 1987, 15 (6) 760-766;

  3. Malet-Martino, M C

    1. 19F nuclear magnetic resonance analysis of the carbamate reaction of alpha-fluoro-beta-alanine (FBAL), the major catabolite of fluoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5'-deoxy-5-fluorouridine.
      R Martino, M C Malet-Martino, C Vialaneix, A Lopez and M Bon
      Drug Metabolism and Disposition November 1987, 15 (6) 897-904;

  4. Malkinson, A M

    1. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
      J A Thompson, A M Malkinson, M D Wand, S L Mastovich, E W Mead, K M Schullek and W G Laudenschlager
      Drug Metabolism and Disposition November 1987, 15 (6) 833-840;

  5. Marriage, H J

    1. Metabolism of (+)-trans-delta 8-tetrahydrocannabinol in the mouse in vitro and in vivo.
      D J Harvey and H J Marriage
      Drug Metabolism and Disposition November 1987, 15 (6) 914-920;

  6. Martino, R

    1. 19F nuclear magnetic resonance analysis of the carbamate reaction of alpha-fluoro-beta-alanine (FBAL), the major catabolite of fluoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5'-deoxy-5-fluorouridine.
      R Martino, M C Malet-Martino, C Vialaneix, A Lopez and M Bon
      Drug Metabolism and Disposition November 1987, 15 (6) 897-904;

  7. Mastovich, S L

    1. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
      J A Thompson, A M Malkinson, M D Wand, S L Mastovich, E W Mead, K M Schullek and W G Laudenschlager
      Drug Metabolism and Disposition November 1987, 15 (6) 833-840;

  8. McLean, M A

    1. Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.
      T B Felder, M A McLean, M L Vestal, K Lu, D Farquhar, S S Legha, R Shah and R A Newman
      Drug Metabolism and Disposition November 1987, 15 (6) 773-778;

  9. Mead, E W

    1. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
      J A Thompson, A M Malkinson, M D Wand, S L Mastovich, E W Mead, K M Schullek and W G Laudenschlager
      Drug Metabolism and Disposition November 1987, 15 (6) 833-840;

  10. Melder, D C

    1. Cryopreservation of rat and dog hepatocytes for studies of xenobiotic metabolism and activation.
      G Powis, K S Santone, D C Melder, L Thomas, D J Moore and T J Wilke
      Drug Metabolism and Disposition November 1987, 15 (6) 826-832;

  11. Meuldermans, W

    1. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
      W Meuldermans, J Hendrickx, W Lauwers, R Hurkmans, E Swysen, J Thijssen, P Timmerman, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1987, 15 (6) 905-913;

  12. Miller, N E

    1. Mechanism-based inactivation of the major beta-naphthoflavone-inducible isozyme of rat liver cytochrome P-450 by the chloramphenicol analog N-(2-p-nitrophenethyl)dichloroacetamide.
      N E Miller and J R Halpert
      Drug Metabolism and Disposition November 1987, 15 (6) 846-851;

  13. Monks, T J

    1. Co-oxidation of 2-bromohydroquinone by renal prostaglandin synthase. Modulation of prostaglandin synthesis by 2-bromohydroquinone and glutathione.
      S S Lau and T J Monks
      Drug Metabolism and Disposition November 1987, 15 (6) 801-807;

  14. Moore, D J

    1. Cryopreservation of rat and dog hepatocytes for studies of xenobiotic metabolism and activation.
      G Powis, K S Santone, D C Melder, L Thomas, D J Moore and T J Wilke
      Drug Metabolism and Disposition November 1987, 15 (6) 826-832;

N

  1. Newman, R A

    1. Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.
      T B Felder, M A McLean, M L Vestal, K Lu, D Farquhar, S S Legha, R Shah and R A Newman
      Drug Metabolism and Disposition November 1987, 15 (6) 773-778;

  2. Nixon, J R

    1. Isolation and identification of major metabolites of tixocortol pivalate in human urine.
      F Chanoine, C Grenot, N Sellier, W E Barrett, R M Thompson, A F Fentiman, J R Nixon, R Goyer and J L Junien
      Drug Metabolism and Disposition November 1987, 15 (6) 868-876;

  3. Nomeir, A A

    1. Disposition, pharmacokinetics, and metabolism of a dermal dose of [14C]2,5-hexanedione in hens.
      E Suwita, A A Nomeir and M B Abou-Donia
      Drug Metabolism and Disposition November 1987, 15 (6) 779-785;

  4. Nystrom, D D

    1. Metabolism and excretion of dinitrobenzenes by male Fischer-344 rats.
      D D Nystrom and D E Rickert
      Drug Metabolism and Disposition November 1987, 15 (6) 821-825;

P

  1. Paulson, G D

    1. Evidence for diazotization of 14C-sulfamethazine [4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzene[U-14C]sulfonamide] in swine. The effect of nitrite.
      G D Paulson and V J Feil
      Drug Metabolism and Disposition November 1987, 15 (6) 841-845;

  2. Powis, G

    1. Cryopreservation of rat and dog hepatocytes for studies of xenobiotic metabolism and activation.
      G Powis, K S Santone, D C Melder, L Thomas, D J Moore and T J Wilke
      Drug Metabolism and Disposition November 1987, 15 (6) 826-832;

  3. Prox, A

    1. Phenolic metabolites of amitriptyline and nortriptyline in rat bile.
      U Breyer-Pfaff, A Prox, H Wachsmuth and P P Yao
      Drug Metabolism and Disposition November 1987, 15 (6) 882-889;
    2. Amitriptyline metabolites in human urine. Identification of phenols, dihydrodiols, glycols, and ketones.
      A Prox and U Breyer-Pfaff
      Drug Metabolism and Disposition November 1987, 15 (6) 890-896;

R

  1. Rauchman, E J

    1. Effects of model traumatic injury on hepatic drug metabolism in the rat. VI. Major detoxification/toxification pathways.
      L K Griffeth, G M Rosen and E J Rauchman
      Drug Metabolism and Disposition November 1987, 15 (6) 749-759;

  2. Remmel, R P

    1. The disposition and pharmacokinetics of ketoconazole in the rat.
      R P Remmel, K Amoh and M M Abdel-Monem
      Drug Metabolism and Disposition November 1987, 15 (6) 735-739;

  3. Rickert, D E

    1. Metabolism and excretion of dinitrobenzenes by male Fischer-344 rats.
      D D Nystrom and D E Rickert
      Drug Metabolism and Disposition November 1987, 15 (6) 821-825;

  4. Rosen, G M

    1. Effects of model traumatic injury on hepatic drug metabolism in the rat. VI. Major detoxification/toxification pathways.
      L K Griffeth, G M Rosen and E J Rauchman
      Drug Metabolism and Disposition November 1987, 15 (6) 749-759;

  5. Ruelius, H W

    1. Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen, and benoxaprofen.
      M el Mouelhi, H W Ruelius, C Fenselau and D M Dulik
      Drug Metabolism and Disposition November 1987, 15 (6) 767-772;

S

  1. Santone, K S

    1. Cryopreservation of rat and dog hepatocytes for studies of xenobiotic metabolism and activation.
      G Powis, K S Santone, D C Melder, L Thomas, D J Moore and T J Wilke
      Drug Metabolism and Disposition November 1987, 15 (6) 826-832;

  2. Schullek, K M

    1. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
      J A Thompson, A M Malkinson, M D Wand, S L Mastovich, E W Mead, K M Schullek and W G Laudenschlager
      Drug Metabolism and Disposition November 1987, 15 (6) 833-840;

  3. Sellier, N

    1. Isolation and identification of major metabolites of tixocortol pivalate in human urine.
      F Chanoine, C Grenot, N Sellier, W E Barrett, R M Thompson, A F Fentiman, J R Nixon, R Goyer and J L Junien
      Drug Metabolism and Disposition November 1987, 15 (6) 868-876;

  4. Shah, R

    1. Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.
      T B Felder, M A McLean, M L Vestal, K Lu, D Farquhar, S S Legha, R Shah and R A Newman
      Drug Metabolism and Disposition November 1987, 15 (6) 773-778;

  5. Sugihara, J

    1. Mechanism of metabolic cleavage of a furan ring.
      T Kobayashi, J Sugihara and S Harigaya
      Drug Metabolism and Disposition November 1987, 15 (6) 877-881;

  6. Suwita, E

    1. Disposition, pharmacokinetics, and metabolism of a dermal dose of [14C]2,5-hexanedione in hens.
      E Suwita, A A Nomeir and M B Abou-Donia
      Drug Metabolism and Disposition November 1987, 15 (6) 779-785;

  7. Swanson, S P

    1. Isolation and characterization of 4'-hydroxy T-2 toxin, a new metabolite of the trichothecene mycotoxin T-2.
      C A Knupp, D G Corley, M S Tempesta and S P Swanson
      Drug Metabolism and Disposition November 1987, 15 (6) 816-820;

  8. Swysen, E

    1. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
      W Meuldermans, J Hendrickx, W Lauwers, R Hurkmans, E Swysen, J Thijssen, P Timmerman, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1987, 15 (6) 905-913;

T

  1. Tempesta, M S

    1. Isolation and characterization of 4'-hydroxy T-2 toxin, a new metabolite of the trichothecene mycotoxin T-2.
      C A Knupp, D G Corley, M S Tempesta and S P Swanson
      Drug Metabolism and Disposition November 1987, 15 (6) 816-820;

  2. Thijssen, J

    1. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
      W Meuldermans, J Hendrickx, W Lauwers, R Hurkmans, E Swysen, J Thijssen, P Timmerman, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1987, 15 (6) 905-913;

  3. Thomas, L

    1. Cryopreservation of rat and dog hepatocytes for studies of xenobiotic metabolism and activation.
      G Powis, K S Santone, D C Melder, L Thomas, D J Moore and T J Wilke
      Drug Metabolism and Disposition November 1987, 15 (6) 826-832;

  4. Thompson, J A

    1. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
      J A Thompson, A M Malkinson, M D Wand, S L Mastovich, E W Mead, K M Schullek and W G Laudenschlager
      Drug Metabolism and Disposition November 1987, 15 (6) 833-840;

  5. Thompson, R M

    1. Isolation and identification of major metabolites of tixocortol pivalate in human urine.
      F Chanoine, C Grenot, N Sellier, W E Barrett, R M Thompson, A F Fentiman, J R Nixon, R Goyer and J L Junien
      Drug Metabolism and Disposition November 1987, 15 (6) 868-876;

  6. Timmerman, P

    1. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
      W Meuldermans, J Hendrickx, W Lauwers, R Hurkmans, E Swysen, J Thijssen, P Timmerman, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1987, 15 (6) 905-913;

V

  1. Vestal, M L

    1. Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.
      T B Felder, M A McLean, M L Vestal, K Lu, D Farquhar, S S Legha, R Shah and R A Newman
      Drug Metabolism and Disposition November 1987, 15 (6) 773-778;

  2. Vialaneix, C

    1. 19F nuclear magnetic resonance analysis of the carbamate reaction of alpha-fluoro-beta-alanine (FBAL), the major catabolite of fluoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5'-deoxy-5-fluorouridine.
      R Martino, M C Malet-Martino, C Vialaneix, A Lopez and M Bon
      Drug Metabolism and Disposition November 1987, 15 (6) 897-904;

W

  1. Wachsmuth, H

    1. Phenolic metabolites of amitriptyline and nortriptyline in rat bile.
      U Breyer-Pfaff, A Prox, H Wachsmuth and P P Yao
      Drug Metabolism and Disposition November 1987, 15 (6) 882-889;

  2. Wand, M D

    1. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
      J A Thompson, A M Malkinson, M D Wand, S L Mastovich, E W Mead, K M Schullek and W G Laudenschlager
      Drug Metabolism and Disposition November 1987, 15 (6) 833-840;

  3. Wilke, T J

    1. Cryopreservation of rat and dog hepatocytes for studies of xenobiotic metabolism and activation.
      G Powis, K S Santone, D C Melder, L Thomas, D J Moore and T J Wilke
      Drug Metabolism and Disposition November 1987, 15 (6) 826-832;

  4. Woestenborghs, R

    1. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
      W Meuldermans, J Hendrickx, W Lauwers, R Hurkmans, E Swysen, J Thijssen, P Timmerman, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1987, 15 (6) 905-913;

Y

  1. Yao, P P

    1. Phenolic metabolites of amitriptyline and nortriptyline in rat bile.
      U Breyer-Pfaff, A Prox, H Wachsmuth and P P Yao
      Drug Metabolism and Disposition November 1987, 15 (6) 882-889;
Back to top

In this issue

Advertisement